Mobia Medical

IPO

Home - Mobia Medical, Inc.

Business Model
B2B
Website
mobia.com
Total Funding
$65.0M
Last Round
$65.0M Series FMar 2025
Rounds
1

About

Mobia Medical, formerly MicroTransponder, develops recovery solutions for people living with chronic ischemic stroke. Its Vivistim Paired VNS Therapy combines vagus nerve stimulation with rehabilitation exercises to help stroke survivors regain meaningful function, independence, and quality of life. The company describes Vivistim as an FDA-approved and clinically validated option for eligible chronic stroke survivors with moderate to severe upper-extremity impairment.

Summary

Mobia Medical is a Healthcare company. It has raised $65.0M in total across 1 round, most recently a $65.0M Series F round in Mar 2025.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOMay 2026
$150.0M

Sign up to see all 2 rounds

Series F through IPO — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mobia Medical on Indexed.vc
<a href="https://indexed.vc/companies/mobia-medical"><img src="https://indexed.vc/api/badge/company/mobia-medical" alt="Mobia Medical on Indexed.vc" width="260" height="76" /></a>